glutamine has been researched along with Lung Neoplasms in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (6.03) | 18.7374 |
| 1990's | 3 (2.59) | 18.2507 |
| 2000's | 12 (10.34) | 29.6817 |
| 2010's | 57 (49.14) | 24.3611 |
| 2020's | 37 (31.90) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, M; Han, T; Lei, J; Lu, Z; Wang, JB; Wang, P; Wang, T; Wang, Y; Xun, W; Yu, B; Zhang, W | 1 |
| Li, Y; Liu, Y; Pan, S; Wang, S; Yan, Q; Zhao, Y | 1 |
| Hong, SE; Jang, SK; Jin, HO; Kim, JY; Park, IC | 1 |
| Baek, GH; Choi, YJ; Jeon, JS; Kang, KW; Kim, S; Kim, SK | 1 |
| Fei, Z; Hong, G; Jie-Cheng, Y; Jin-Xiang, Y; Long, T; Nai-Dong, W; Xiao, S; Xiu-Rong, L | 1 |
| He, P; Hou, Y; Li, N; Liu, Z; Yang, Y; Zhang, X | 1 |
| Li, H; Liu, S; Lu, M; Sun, L; Tang, L; Zhang, G | 1 |
| Luo, H; Peng, J; Yuan, Y | 1 |
| Feng, Y; Han, J; Ren, H; Sheng, Y; Sun, X; Wang, Y; Yang, T; Zhou, D | 1 |
| Fujita, K; Hino, H; Hino, R; Kamiya, M; Kawashima, S; Kitano, K; Kojima, R; Komatsu, T; Konoeda, C; Nagano, M; Nakajima, J; Ogasawara, A; Sato, M; Urano, Y; Yanagiya, M; Yoshida, D; Yoshioka, T | 1 |
| Huang, M; Lubet, RA; Montuenga, LM; Pan, J; Sei, S; Shoemaker, RH; Slusher, BS; Wang, Y; Xiong, D; You, M; Zhang, Q | 1 |
| Hong, J; Jie, X; Li, Q; Li, Z; Rao, X; Wang, J; Wu, G; Xu, Y; Zhou, R; Zhou, X; Zhu, K | 1 |
| Lv, H; Peng, L; Shi, Z; Sui, A; Wang, M; Zhang, F; Zhang, Y | 1 |
| Du, J; Gu, W; Liu, J; Ma, G; Shen, H; Wang, Y; Zheng, H | 1 |
| Chen, L; Liu, X; Wang, T | 1 |
| Cai, J; Dong, L; Huang, Y; Zhang, X; Zheng, Y | 1 |
| DI, LQ; Huang, X; Lu, YY; Luo, ZC; Qi, MY; Shan, JJ; Zhang, W | 1 |
| Chen, S; Kan, J; Ke, B; Shi, L; Wang, S; Zhang, B; Zhuo, L | 1 |
| Cai, Y; Dong, Z; Wang, J | 1 |
| Chen, H; Dong, G; Fang, P; Han, C; Hu, Z; Liu, T; Ma, Z; Meng, F; Qian, X; Qiu, M; Shen, H; Wang, C; Wang, J; Wang, S; Wang, X; Xu, L; Yin, R; Yin, W; Zhang, E; Zhu, H; Zuo, X | 1 |
| Aa, J; Ao, L; Hong, X; Li, H; Liu, J; Rao, X; Sun, M; Wang, G; Wang, H; Wang, J; Wang, Q; Wang, X; Wu, M; Yao, L; Zhou, F | 1 |
| Hanada, K; Itatani, Y; Kawada, K; Maekawa, H; Miyoshi, H; Nishikawa, G; Obama, K; Taketo, MM | 1 |
| Chen, J; Chen, Z; Du, H; Gong, X; Hu, M; Huang, G; Wei, J; Yu, W; Zhang, L | 1 |
| Chen, JS; Chen, TE; Chen, YC; Cheng, ML; Huang, RS; Lin, YS; Lynn, KS; Shah, P | 1 |
| Chen, Z; Deng, Z; He, J; Luo, Z; Mo, X; Shen, X; Tan, W; Yang, J; Yu, F | 1 |
| Dai, J; Hu, Q; Qin, Y; Yu, H; Zhang, J; Zhang, L; Zhang, P; Zhang, Z; Zhu, X | 1 |
| Du, M; Huang, X; Li, Z; Lin, H; Pei, S; Wang, Q; Wu, L; Xia, Z; Xie, J; Zhang, P | 1 |
| Chen, X; Du, T; Hu, P; Zhu, X | 1 |
| Chen, H; Huang, Y; Li, C; Li, Z; Liang, Y; Liu, Y; Wu, Z; Zhang, L | 1 |
| Liu, J; Pei, J; Wang, B; Xu, S; Yu, J | 1 |
| Cheng, Y; Pan, Y | 1 |
| Bussink, J; Kaanders, JHAM; Lok, J; Looijen-Salamon, MG; Meijer, TWH; Span, PN; Tops, B; van den Heuvel, M | 1 |
| Hong, SE; Hong, YJ; Jang, SK; Jin, HO; Kim, H; Kim, JY; Kim, YS; Lee, JK; Oh, AC; Park, IC; Sim, JH | 1 |
| Clench, MR; Cole, LM; Cross, NA; Duckett, CJ; Flint, LE; Goodwin, RJA; Hamm, G; Ling, S; Ready, JD; Smith, DP | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Deng, J; Guo, W; Hu, M; Jing, B; Kuang, Y; Li, K; Li, Q; Liao, Y; Lin, SH; Ling, J; Liu, S; Song, H; Sun, B; Tong, L; Wang, Q; Wang, T; Wu, Y; Xu, D; Yao, F; Yin, H; Zhou, BP | 1 |
| Chen, Y; Guo, J; Li, J; Peng, F; Peng, J; Rao, T; Tan, Z; Wang, Y; Yu, J; Zhou, H | 1 |
| Billingham, L; Gaskell, C; Gaunt, C; Jackson, A; Pascoe, J; Steven, N; Thompson, J | 1 |
| Bing, ZX; Li, DQ; Wang, GG; Wang, TG; Wang, YQ; Zhang, JQ | 1 |
| Johansson, ME; Mohlin, S; Munksgaard Thorén, M; Påhlman, S; Planck, M; Staaf, J; Vaapil, M | 1 |
| Chen, S; Feun, LG; Kandemir, H; Kuo, MT; Li, YY; Nguyen, DJM; Prince, JS; Savaraj, N; Shah, S; Wangpaichitr, M; Wu, C | 1 |
| Byun, JK; Choi, YK; Hwang, I; Jeon, HJ; Jeong, JY; Kim, JH; Kim, MK; Lee, IK; Lee, SY; Lee, YM; Park, KG | 1 |
| Castegna, A; De Tullio, G; Ghesquière, B; Guarini, A; Hooper, DC; Lamers, WH; Martín-Pérez, R; Mazzone, M; McVicar, DW; Menga, A; Palmieri, EM; Quinto, A; Riera-Domingo, C | 1 |
| Allaj, V; Bauer, MR; Bhutkar, A; Bronson, RT; Davidson, SM; Davies, A; Dolgalev, I; Ellis, DC; Goparaju, C; Heguy, A; Jacks, T; Karakousi, TR; LeBoeuf, SE; Martinez, B; Moreira, AL; Papagiannakopoulos, T; Pass, HI; Poirier, JT; Prigge, JR; Romero, R; Rudin, CM; Sánchez-Rivera, FJ; Sayin, VI; Schmidt, EE; Singh, SX; Subbaraj, L; Thomas, CJ; Vander Heiden, MG | 1 |
| Choi, JW; Hua, TNM; Jeong, Y; Jung, SH; Kang, BH; Kim, MK; Phan, ANH; Vo, VTA; Yong, SJ | 1 |
| Cerione, RA; Katt, WP; Lukey, MJ | 1 |
| Badran, K; Bailey, ST; Bernthal, NM; Braas, D; Christofk, HR; Demo, S; Dubinett, SM; Federman, N; Fishbein, MC; Fridman, D; Go, J; Graeber, TG; Gricowski, M; Ibarra, J; Lee, JT; Li, R; Momcilovic, M; Parlati, F; Phelps, ME; Sadeghi, S; Shackelford, DB; Shuman, R; St John, M; Walser, TC; Yanagawa, J | 1 |
| Eisenberg, R; Harris, BK; Heidi, C; Hoeksema, MD; Ji, X; Massion, PP; Qian, J; Rahman, SMJ; Rathmell, JC; Siska, PJ; Trenary, IA; Young, JD; Zou, Y | 1 |
| Deng, H; Feng, M; Li, L; Li, Z; Peng, X; Wang, C; Wang, Z; Wu, J; Yang, Z | 1 |
| Badrzadeh, L; Bitarafan-Rajabi, A; Ghoreishi, SM; Khalaj, A; Mohammadzadeh, P; Mousavi Motlagh, SS; Sabzevari, O; Shafiee Ardestani, M | 1 |
| Dyer, A; Freedman, J; Frost, S; Jacobus, EJ; Jakeman, P; Schoeps, B; Scott, EM; Seymour, LW | 1 |
| Biemans, R; Bussink, J; Dubois, LJ; Meijer, TWH; Peeters, WJM; Span, PN; van Gisbergen, MW; Venhuizen, JH | 1 |
| Boysen, G; Davis, MA; Dings, RPM; Griffin, RJ; Jamshidi-Parsian, A; Kore, RA; Siegel, ER; Simecka, CM | 1 |
| Adriaensens, P; Derveaux, E; Graulus, GJ; Guedens, W; Mesotten, L; Noben, JP; Thomeer, M; Vanhove, K | 1 |
| Chang, CY; Chang, SC; Hung, JC; Lai, YC | 1 |
| Cao, J; Gan, M; Guo, M; Han, T; Jin, J; Wang, JB; Wang, P; Wang, Y; Xie, C; Zhang, S | 1 |
| Aryee, MJ; Berker, Y; Cheng, LL; Christiani, DC; Dinges, SS; Habbel, P; Kurth, J; Mark, E; Nowak, J; Schuler, A; Su, L; Vandergrift, LA; Wagner, I | 1 |
| Chen, GJ; Guo, JY; Karsli-Uzunbas, G; Mathew, R; McMahon, M; Price, SM; Strohecker, AM; White, E | 1 |
| Attili, VS; Jamil, K; Madireddy, UR; Natukula, K; Pingali, UR | 1 |
| Chen, S; Guan, JL | 1 |
| Foygel, K; Ilovich, O; Paulmurugan, R; Sekar, TV | 1 |
| Chen, Z; Gu, X; Lv, W; Ma, X; Wang, Y; Wu, Q; Yan, C; Yu, X | 1 |
| Gul, K; Muge, A; Sehri, E; Taner, A | 1 |
| Arnold, JM; Bhowmik, SK; Brennan, CA; Chinnaiyan, AM; Coarfa, C; Dasgupta, S; Ittmann, MM; Kaushik, AK; Long, W; Mitsiades, N; O'Malley, BW; Putluri, N; Rajapakshe, K; Sreekumar, A; Stashi, E; Wang, J; Zhang, B | 1 |
| Deng, J; Fang, W; Lu, J; Qiu, F; Yang, L; Zhang, H; Zhang, L; Zhou, Y | 1 |
| Boyd, KL; Chen, H; Eisenberg, R; Harris, BK; Harris, FT; Hassanein, M; Hoeksema, MD; Jacobovitz, M; Ji, X; Massion, PP; Qian, J; Wang, J | 1 |
| Boyd, K; Buck, JR; Harris, BK; Hassanein, M; Hight, MR; Hoeksema, MD; Manning, HC; Massion, PP; Nickels, ML; Tantawy, MN | 1 |
| Anand, SK; Beer, DG; Carskadon, SL; Chakravarthi, BV; Chen, G; Chinnaiyan, AM; Giordano, TJ; Goswami, MT; Palanisamy, N; Pathi, SS; Thomas, DG; Varambally, S | 1 |
| Chakrabarti, G | 1 |
| Artyomov, MN; Avizonis, D; Blagih, J; Bridon, G; Choinière, L; Coelho, PP; Elder, DJ; Flynn, BR; Gingras, MC; Griss, T; Jones, RG; Loginicheva, E; Ntimbane, T; Pause, A; Raissi, TC; Samborska, B; Sergushichev, A; Tavaré, JM; Thomas, EC; Vincent, EE | 1 |
| Ahn, JM; Chen, PH; DeBerardinis, RJ; Dospoy, P; Frink, RE; Huffman, KE; Kim, DH; Kim, HS; Kim, J; Larsen, JE; Lewis, C; Lou, TF; Ma, X; Minna, JD; Sethuraman, D; Srivastva, P; Um, SW; White, MA; Yoo, H | 1 |
| Kim, BM; Kim, YJ; Lee, G; Lee, KH; Lee, YM; Lim, BO; Lim, JH; Oh, TI; Shim, DW | 1 |
| Boysen, G; Desai, A; Griffin, RJ; Hiatt, G; Jamshidi-Parsian, A; Penney, RB; Sappington, DR; Siegel, ER | 1 |
| de Abreu, MG; Oliveira, GP; Pelosi, P; Rocco, PR | 1 |
| Baek, MJ; Han, JH; Jeong, D; Kim, CJ; Kim, HJ; Koh, YW; Kwon, HY; Lee, CK; Lee, MS | 1 |
| Broggini, M; Brunelli, L; Caiola, E; Marabese, M; Pastorelli, R | 1 |
| Gul, K; Mehmet, K; Meryem, A | 1 |
| Bartlebaugh, J; Bauer, MR; Bhutkar, A; Davidson, SM; Heimann, M; Jacks, T; Papagiannakopoulos, T; Subbaraj, L; Vander Heiden, MG | 1 |
| Chan, CS; Guo, JY; Khor, S; Laddha, SV; Ma, S; Rabinowitz, JD; Teng, X; Van Nostrand, SC; White, E; Yang, Y | 1 |
| Kageyama, S; Komatsu, M; Matsumoto, Y; Moriyama, M; Saijo, Y; Satoh, S; Tsuchida, M; Ye, X; Zhou, Q | 1 |
| Gabano, E; Osella, D; Ravera, M; Tinello, S; Zanellato, I | 1 |
| Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
| Jiang, ZF; Ning, YJ; Wang, M; Xu, JL | 1 |
| Bailey, ST; Braas, D; Christofk, HR; Czernin, J; Demo, S; Dubinett, SM; Emberley, E; Fishbein, MC; Garon, E; Graeber, T; Gross, M; Jackson, NJ; Janes, J; Krysan, K; Lee, JT; Mackinnon, A; Magyar, C; Momcilovic, M; Pan, A; Parlati, F; Rodriguez, M; Sadeghi, S; Shackelford, DB; Walser, TC; Works, M; Zhang, W | 1 |
| Hanse, EA; Kachman, M; Kelekar, A; Lowman, XH; Ruan, C; Wang, D | 1 |
| Onal, C; Topkan, E; Yavuz, AA; Yavuz, MN | 1 |
| Gunduz, M; Mita, Y; Naomoto, Y; Ouchida, M; Sakai, A; Shimizu, K; Tanabe, S; Toyooka, S; Yamamoto, H; Yasuda, Y | 1 |
| Chen, B; Dai, S; Gao, M; Gong, W; He, F; Zhang, L; Zhang, Y; Zheng, Y | 1 |
| Budinger, GR; Chandel, NS; Hamanaka, R; Joseph, J; Kalyanaraman, B; Lopez, M; Mutlu, GM; Weinberg, F; Weinberg, S; Wheaton, WW | 1 |
| Beuster, G; Kaleta, C; Kiehntopf, M; Ristow, M; Schuster, S; Steinberg, P; Thierbach, R; Zarse, K | 1 |
| Allwood, JW; Blackhall, FH; Brown, M; Dive, C; Dunn, W; Goodacre, R; Priest, L; Simpson, K; Vaughan, AA; Wedge, DC; Whetton, AD | 1 |
| Im, SY; Kim, HA; Kim, KJ; Lee, HK; Yoon, SY | 1 |
| Allen, TD; Alonso, FJ; Bishop, JM; Chen, X; Fan, TW; Ferraris, DV; Higashi, RM; Matés, JM; Seo, Y; Tsukamoto, T; Wang, C; Yuneva, MO | 1 |
| Bachman, KE; Jing, J; van den Heuvel, AP; Wooster, RF | 1 |
| Parlak, C; Pehlivan, B; Topkan, E; Topuk, S | 1 |
| Alborn, WE; Chen, H; Clark, JE; Eisenberg, R; Harris, BK; Hassanein, M; Hoeksema, MD; Massion, PP; Qian, J; Shiota, M | 1 |
| LORINCZ, AB; RYAN, WL | 1 |
| Matono, K; Ogata, Y; Shirouzu, K | 1 |
| Hamajima, N; Ito, H; Kang, D; Lee, KM; Matsuo, K; Mitsudomi, T; Saito, T; Sato, S; Sugiura, T; Tajima, K; Ueda, R; Yasue, T; Yoo, KY | 1 |
| Araki, Y; Matono, K; Ogata, Y; Shirouzu, K; Tsuda, H | 1 |
| Devine, P; Machtay, M; Washam, C | 1 |
| Jia, G; Jin, Y; Liu, N; Liu, SW; Liu, YQ; Yan, L; Zhao, XH | 1 |
| Bikfalvi, A; Bouchecareilh, M; Chevet, E; Déléris, G; Drogat, B; Moenner, M; North, S; Petibois, C | 1 |
| Kaur, P; Pachouri, SS; Singh, J; Sobti, RC | 1 |
| DeMarchi, M; Ghio, P; Giachino, DF; Gregori, D; Mandrile, G; Novello, S; Regazzoni, S; Scagliotti, GV; Selvaggi, G | 1 |
| Algara, M; Dengra, J; Fernández-Velilla, E; Foro, P; Lacruz, M; Lozano, J; Membrive, I; Quera, J; Reig, A; Rodríguez, N; Sanz, X; Viñals, P | 1 |
| Aaronson, SA; Dunn, CY; Reddy, EP; Rhim, JS; Srivastava, SK; Yuasa, Y | 1 |
| Bartlett, DL; Charland, S; Torosian, MH | 1 |
| Hahn, FF; Kelly, G; Stegelmeier, BL | 1 |
| Akasaka, K; Endo, K; Ishima, R; Konishi, J; Nakai, T; Sakahara, H | 1 |
| Belinsky, SA; Bocklage, TJ; Cook, DL; Crowell, RE; Divine, KK; Gilliland, FD; Stidley, CA | 1 |
| Huber, KR; Roberts, J; Rosenfeld, H | 1 |
| Huber, KR; Mayer, EP; Mitchell, DF; Roberts, J | 1 |
| Roberts, J; Steele, D; Tannock, IF | 1 |
| Alderman, EM; Fett, JW; Lobb, RR | 1 |
| Jezzi, B | 1 |
4 review(s) available for glutamine and Lung Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Glutamine Addiction and Therapeutic Strategies in Lung Cancer.
Topics: Animals; Biological Transport; Glutamine; Humans; Lung Neoplasms; Metabolic Networks and Pathways; Molecular Targeted Therapy; Neoplasm Metastasis; Signal Transduction | 2019 |
The functional polymorphism of NBS1 p.Glu185Gln is associated with an increased risk of lung cancer in Chinese populations: case-control and a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Case-Control Studies; Cell Cycle Proteins; China; Female; Gene Frequency; Genetic Predisposition to Disease; Glutamic Acid; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Polymorphism, Single Nucleotide; Risk Factors | 2014 |
Exogenous Glutamine in Respiratory Diseases: Myth or Reality?
Topics: Asthma; Cystic Fibrosis; Glutamine; Humans; Lung; Lung Neoplasms; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome | 2016 |
5 trial(s) available for glutamine and Lung Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).
Topics: Arginine; Cachexia; Female; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2021 |
Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dietary Supplements; Esophagitis; Female; Glutamine; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Survival Analysis | 2019 |
Pilot study of accelerated radiotherapy with concurrent chemotherapy for stage III non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dietary Supplements; Dose Fractionation, Radiation; Glutamine; Humans; Lung Neoplasms; Paclitaxel; Pilot Projects; Radiotherapy, Conformal | 2005 |
Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Topics: Adult; Aged; Amino Acid Substitution; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; DNA-Binding Proteins; Female; Glutamine; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Platinum Compounds; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Survival; Treatment Outcome; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2007 |
108 other study(ies) available for glutamine and Lung Neoplasms
| Article | Year |
|---|---|
FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Apoptosis Regulatory Proteins; Autophagy; Glutaminase; Glutamine; Humans; Lung Neoplasms; TOR Serine-Threonine Kinases | 2022 |
Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Topics: Amino Acid Transport System ASC; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glutamine; Humans; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Minor Histocompatibility Antigens; RNA, Circular | 2022 |
Amino acid deprivation induces AKT activation by inducing GCN2/ATF4/REDD1 axis.
Topics: Activating Transcription Factor 4; Amino Acids; Carcinoma, Non-Small-Cell Lung; Glutamine; Humans; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 1; Proto-Oncogene Proteins c-akt | 2021 |
Heterogeneity of glutamine metabolism in acquired-EGFR-TKI-resistant lung cancer.
Topics: Apoptosis; Benzeneacetamides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Drug Resistance, Neoplasm; ErbB Receptors; Glutamine; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Tandem Mass Spectrometry; Thiadiazoles; Xenograft Model Antitumor Assays | 2022 |
ANGPTL4 regulate glutamine metabolism and fatty acid oxidation in nonsmall cell lung cancer cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Fatty Acids; Glutamine; Glycolysis; Lung Neoplasms; Mice | 2022 |
Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutamine; Humans; Ketones; Lung Neoplasms; Mice; Mitochondria; NAD | 2022 |
Preparation of Nereid oligopeptide and investigation of the mechanism underlying the induction of apoptosis in human lung cancer H1299 cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Glutamine; Humans; Lung Neoplasms; Neptune; Oligopeptides; Proto-Oncogene Proteins c-bcl-2 | 2022 |
CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
Topics: Amino Acid Transport System ASC; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Glutamine; Humans; Lung Neoplasms; MicroRNAs; Minor Histocompatibility Antigens; RNA, Circular | 2023 |
Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs.
Topics: Glutamine; Humans; Lung Neoplasms; RNA, Long Noncoding; Tumor Microenvironment | 2022 |
Rapid imaging of lung cancer using a red fluorescent probe to detect dipeptidyl peptidase 4 and puromycin-sensitive aminopeptidase activities.
Topics: Alanine; Aminopeptidases; Dipeptidyl Peptidase 4; Fluorescent Dyes; Glutamine; Humans; Lung Neoplasms; Rhodamines; Silicon | 2022 |
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer.
Topics: Animals; Azo Compounds; Cancer Vaccines; Caproates; Carcinogenesis; ErbB Receptors; Glutamine; Immunotherapy; Lung Neoplasms; Mice; Tumor Microenvironment | 2022 |
Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer.
Topics: Amino Acid Transport System ASC; Amino Acids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Glutamine; Humans; Lung Neoplasms; Minor Histocompatibility Antigens; Pyridines | 2022 |
hsa_circ_0000518 Facilitates Non-Small-Cell Lung Cancer Progression via Moderating miR-330-3p and Positively Regulating SLC1A5.
Topics: 3' Untranslated Regions; Amino Acid Transport System ASC; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; MicroRNAs; Minor Histocompatibility Antigens; RNA, Circular | 2022 |
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Immunotherapy; Lung Neoplasms; Prognosis; Tumor Microenvironment | 2022 |
Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Glutaminase; Glutamine; Humans; Lung Neoplasms; MicroRNAs | 2023 |
Circular RNA hsa_circ_0018189 drives non-small cell lung cancer growth by sequestering miR-656-3p and enhancing xCT expression.
Topics: Amino Acid Transport System y+; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Mice; MicroRNAs; RNA, Circular | 2022 |
[Mechanism of Cordyceps militaris against non-small cell lung cancer: based on serum metabolomics].
Topics: Alanine; Animals; Arginine; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cordyceps; Glutamic Acid; Glutamine; Glyoxylates; Humans; Lung Neoplasms; Metabolomics; Mice; Mice, Nude; Nitrogen; Phenylalanine; RNA, Transfer; Tryptophan; Tyrosine | 2022 |
Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Computational Biology; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Mice; MicroRNAs; Molecular Chaperones; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Tetratricopeptide Repeat | 2023 |
Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis.
Topics: Amino Acid Transport System ASC; Animals; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Glutamates; Glutamine; Humans; Ketoglutaric Acids; Lung Neoplasms; Mice; MicroRNAs; Minor Histocompatibility Antigens; RNA, Circular | 2022 |
Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma.
Topics: Adenocarcinoma; Cancer-Associated Fibroblasts; Cytokines; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Humans; In Situ Hybridization, Fluorescence; Large Neutral Amino Acid-Transporter 1; Luciferases; Lung; Lung Neoplasms; NF-kappa B; RNA, Long Noncoding; Tumor Microenvironment | 2022 |
Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glutamate Dehydrogenase; Glutamine; Humans; Lung Neoplasms; Snail Family Transcription Factors | 2022 |
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
Topics: Animals; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Aspartic Acid; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Glutamine; Humans; Lung Neoplasms; Mice; Mice, Nude; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2022 |
Single-cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers.
Topics: Apolipoproteins E; Gene Expression; Glutamate-Ammonia Ligase; Glutamine; Humans; Lung Neoplasms; Phenotype; Single-Cell Analysis; Spatial Analysis; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
Probing Folate-Responsive and Stage-Sensitive Metabolomics and Transcriptional Co-Expression Network Markers to Predict Prognosis of Non-Small Cell Lung Cancer Patients.
Topics: Amino Acid Transport System ASC; Carcinoma, Non-Small-Cell Lung; Folic Acid; Glutamine; Humans; Lung Neoplasms; Metabolomics; Minor Histocompatibility Antigens; Prognosis; Tandem Mass Spectrometry | 2022 |
CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7/c-Myc-dependent axis.
Topics: Cell Line, Tumor; Cell Proliferation; F-Box-WD Repeat-Containing Protein 7; Glutamine; Humans; Lung Neoplasms; Signal Transduction; Small Cell Lung Carcinoma | 2023 |
ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Citric Acid Cycle; Ferroptosis; Glutamine; Humans; Lung Neoplasms | 2023 |
Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Galectin 3; Glutamine; Humans; Lung Neoplasms; Machine Learning; Tumor Microenvironment | 2023 |
Circ-PDZD8 promotes cell growth and glutamine metabolism in non-small cell lung cancer by enriching LARP1 via sequestering miR-330-5p.
Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Glutamine; Humans; Lung Neoplasms; MicroRNAs; RNA, Circular | 2023 |
Evaluation of (2S,4S)-4-[
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioma; Glutamine; Lung Neoplasms; Male; Mice; Mice, Nude; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2023 |
System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Aspartate Aminotransferase, Cytoplasmic; Glutamates; Glutamine; Humans; Immunotherapy; Lung Neoplasms; Mice; Mice, Inbred C57BL; Pyruvates; Transaminases; Tumor Microenvironment | 2023 |
Splicing factor proline- and glutamine-rich regulates cytotoxic T lymphocytes-mediated cytotoxicity on non-small cell lung cancer by directly binding to PD-L1 3'UTR.
Topics: 3' Untranslated Regions; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Glutamine; Humans; Leukocytes, Mononuclear; Lung Neoplasms; PTB-Associated Splicing Factor; RNA Splicing Factors; T-Lymphocytes, Cytotoxic | 2023 |
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Fluorescent Antibody Technique; Genetic Association Studies; Genetic Predisposition to Disease; Glucose; Glutamine; Humans; Lung Neoplasms; Mutation; Neoplasm Staging | 2019 |
Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions.
Topics: Activating Transcription Factor 4; Benzeneacetamides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Gene Knock-In Techniques; Glutaminase; Glutamine; Humans; Lung; Lung Neoplasms; Radiation Tolerance; RNA, Messenger; Thiadiazoles; Transaminases | 2019 |
Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging.
Topics: Adenocarcinoma of Lung; Citric Acid; Glutamine; Humans; Lactic Acid; Lung Neoplasms; Multimodal Imaging; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2020 |
Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc
Topics: Animals; Antiporters; Cell Death; Cell Line, Tumor; Cystine; Excitatory Amino Acid Transporter 3; Glutamic Acid; Glutamine; Glutathione; Lung Neoplasms; Mice; Mice, Nude; Oxidative Stress; Receptors, G-Protein-Coupled; Stress, Physiological; Up-Regulation | 2021 |
In vitro and in vivo analysis of metabolites involved in the TCA cycle and glutamine metabolism associated with cisplatin resistance in human lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Glutamine; Humans; Lung Neoplasms; Mice; Tandem Mass Spectrometry | 2021 |
Silencing of circ_0000517 suppresses proliferation, glycolysis, and glutamine decomposition of non-small cell lung cancer by modulating miR-330-5p/YY1 signal pathway.
Topics: Adult; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Female; Glutamine; Glycolysis; Humans; Lung Neoplasms; Male; Mice; MicroRNAs; Middle Aged; RNA, Circular; Signal Transduction; YY1 Transcription Factor | 2021 |
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Female; Gene Amplification; Gene Expression; Gene Knockdown Techniques; Genes, myc; Glutamine; Glycolysis; Heterografts; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Models, Biological; Small Cell Lung Carcinoma | 2017 |
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Energy Metabolism; Gene Expression; Glucose; Glutamic Acid; Glutamine; Glycolysis; Heterografts; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Mice; Mitochondria; Models, Biological; NAD; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Riluzole | 2017 |
A Positive Feedback Loop between Sestrin2 and mTORC2 Is Required for the Survival of Glutamine-Depleted Lung Cancer Cells.
Topics: Cell Survival; Female; Glutamine; Humans; Lung Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Neoplasm Proteins; Nuclear Proteins; Tumor Cells, Cultured | 2017 |
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Movement; Endothelial Cells; Enzyme Inhibitors; Glucose; Glutamate-Ammonia Ligase; Glutamine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Injections, Subcutaneous; Interleukin-10; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Macrophages; Methionine Sulfoximine; Mice; Mice, Knockout; Monocytes; Neovascularization, Pathologic; Primary Cell Culture; Succinic Acid; T-Lymphocytes, Cytotoxic | 2017 |
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Clustered Regularly Interspaced Short Palindromic Repeats; Genes, ras; Glutaminase; Glutamine; Humans; Hydrolysis; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Mice | 2017 |
TRAP1 Inhibition Increases Glutamine Synthetase Activity in Glutamine Auxotrophic Non-small Cell Lung Cancer Cells.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Glutamate-Ammonia Ligase; Glutamine; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Macrocyclic Compounds; Molecular Targeted Therapy; Terphenyl Compounds | 2018 |
Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential.
Topics: Carcinoma, Squamous Cell; Glutaminase; Glutamine; Glycogen Synthase Kinase 3; Humans; Lung Neoplasms | 2018 |
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
Topics: Animals; Benzeneacetamides; Boron Compounds; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glutamine; Glycine; Glycogen Synthase Kinase 3; Glycolysis; Humans; Ki-67 Antigen; Lung Neoplasms; Mice; Neoplasm Transplantation; Signal Transduction; Thiadiazoles | 2018 |
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.
Topics: 3T3 Cells; A549 Cells; Amino Acid Transport System y+; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystine; Cytoplasm; Disease Progression; Female; Glutamine; Humans; Lung Neoplasms; Male; Mice; Middle Aged | 2018 |
Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Genetic Therapy; Glutamine; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Minor Histocompatibility Antigens; Nanoparticles; Peptides; RNA, Small Interfering; Tumor Microenvironment | 2018 |
Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations.
Topics: Animals; Dendrimers; Glutamine; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Molecular Imaging; Nanoparticles; Radiopharmaceuticals; Technetium; Tissue Distribution; Tumor Cells, Cultured | 2018 |
Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells.
Topics: A549 Cells; Adenoviridae; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Genome, Viral; Glutamine; Glycolysis; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Nude; Oncolytic Viruses; Ovarian Neoplasms; Oxidative Phosphorylation; Random Allocation; Virus Replication | 2019 |
Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Glucose; Glutaminase; Glutamine; Glycolysis; Humans; Indazoles; Lung Neoplasms; Radiation Tolerance; X-Rays | 2018 |
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
Topics: Animals; Benzeneacetamides; Cell Line, Tumor; Female; Glutaminase; Glutamine; Glutathione; Humans; Lung Neoplasms; Male; Mice; Radiation Tolerance; Thiadiazoles; Xenograft Model Antitumor Assays | 2019 |
A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer.
Topics: A549 Cells; Apc10 Subunit, Anaphase-Promoting Complex-Cyclosome; Autophagy; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cytoplasm; Disease Progression; G1 Phase; Glutaminase; Glutamine; Humans; Lung Neoplasms; Resting Phase, Cell Cycle; RNA, Small Interfering; Signal Transduction; Transfection | 2019 |
Magnetic Resonance Spectroscopy-based Metabolomic Biomarkers for Typing, Staging, and Survival Estimation of Early-Stage Human Lung Cancer.
Topics: Aged; Biomarkers; Female; Glutamine; Glycine; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Neoplasm Staging; Survival Analysis; Valine | 2019 |
Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors.
Topics: Adenocarcinoma; Adenoma; Adenoma, Oxyphilic; Animals; Autophagy; Autophagy-Related Protein 7; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Gene Deletion; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Mice; Microtubule-Associated Proteins; Mitochondria; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins B-raf; Tumor Suppressor Protein p53 | 2013 |
The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
Topics: Adenocarcinoma; Arginine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Codon; DNA; DNA-Binding Proteins; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; India; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Risk Factors; Survival Rate; X-ray Repair Cross Complementing Protein 1 | 2013 |
Tumor-promoting and -suppressive roles of autophagy in the same mouse model of BrafV600E-driven lung cancer.
Topics: Animals; Autophagy; Autophagy-Related Protein 7; Glutamine; Humans; Lung Neoplasms; Microtubule-Associated Proteins; Mitochondria; Proto-Oncogene Proteins B-raf | 2013 |
Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.
Topics: Animals; Antineoplastic Agents; Aziridines; Disease Models, Animal; Genetic Therapy; Glutamine; Lung Neoplasms; Mice; Neoplasm Metastasis; Nitroreductases; Optical Imaging; Organometallic Compounds; Prodrugs; Radiography; Thymidine Kinase; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |
Pressurized CEC coupled with QTOF-MS for urinary metabolomics.
Topics: Aged; Biomarkers; Capillary Electrochromatography; Case-Control Studies; Discriminant Analysis; Female; Glutamine; Humans; Lung Neoplasms; Male; Metabolome; Metabolomics; Middle Aged; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Oral glutamine supplementation reduces radiotherapy- induced esophagitis in lung cancer patients.
Topics: Dietary Supplements; Esophagitis; Glutamine; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Lung Neoplasms; Prospective Studies; Quality of Life; Radiation Injuries; Radiotherapy Dosage; Tumor Necrosis Factor-alpha | 2015 |
Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.
Topics: Animals; Cell Survival; Energy Metabolism; Gene Expression Regulation, Neoplastic; Glutamine; HeLa Cells; Humans; Lipogenesis; Lung Neoplasms; Male; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Nuclear Receptor Coactivator 2; Oxidation-Reduction; Prostatic Neoplasms; Transcription, Genetic | 2015 |
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
Topics: Amino Acid Transport System ASC; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Gene Knockdown Techniques; Glutamine; Humans; Lung Neoplasms; Mice; Minor Histocompatibility Antigens; Molecular Targeted Therapy; Prognosis; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2015 |
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.
Topics: Amino Acid Transport System ASC; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colonic Neoplasms; ErbB Receptors; Female; Glutamine; Humans; Lung Neoplasms; Male; Mice, Nude; Minor Histocompatibility Antigens; Mutation; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2016 |
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
Topics: Adenocarcinoma; Aged; Amidophosphoribosyltransferase; Aneuploidy; Animals; Biomarkers, Tumor; Carboxy-Lyases; Cell Line, Tumor; Cell Proliferation; Chickens; Diazooxonorleucine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Peptide Synthases; Prognosis; Purines | 2015 |
Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer.
Topics: Animals; Aspartate Aminotransferase, Cytoplasmic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Databases, Factual; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, ras; Glutamine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Malate Dehydrogenase; Mice; Mice, Transgenic; Mutation, Missense; NADP; Neoplasm Proteins; Oxidation-Reduction; Point Mutation; Prognosis; Radiation Tolerance; Recombinant Fusion Proteins; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Tumor Stem Cell Assay; Up-Regulation | 2015 |
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
Topics: Adaptation, Physiological; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Gene Expression Regulation, Neoplastic; Gluconeogenesis; Glucose; Glutamine; Humans; Lung Neoplasms; Metabolomics; Mice; Mice, Nude; Mitochondria; Neoplasms; Phosphoenolpyruvate; Phosphoenolpyruvate Carboxykinase (ATP); Purines; Pyruvic Acid; Serine | 2015 |
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Topics: Acetyltransferases; Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Blood-Brain Barrier; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; RNA, Small Interfering; Sequence Analysis, RNA | 2016 |
Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress.
Topics: Animals; Apigenin; Apoptosis; Benzophenanthridines; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glutamine; Humans; Lung Neoplasms; Mice; NADP; Oxidative Stress; Reactive Oxygen Species | 2016 |
Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines.
Topics: Cell Line, Tumor; Glutamine; Glutathione; Humans; Lung Neoplasms; Radiation Tolerance; Sulfides; Thiadiazoles; X-Rays | 2016 |
Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; DNA, Neoplasm; ErbB Receptors; Female; Genes, erbB-1; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Risk Factors; Smoking; Survival Analysis | 2016 |
Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Metabolomics; Mice; Mutation; Neoplasm Transplantation; Proto-Oncogene Proteins p21(ras) | 2016 |
The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Combined Modality Therapy; Dietary Supplements; Esophagitis; Female; Follow-Up Studies; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Injuries; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tumor Burden; Weight Loss | 2017 |
Circadian Rhythm Disruption Promotes Lung Tumorigenesis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carcinogenesis; Cell Proliferation; Cell Transformation, Neoplastic; Cellular Reprogramming; Circadian Rhythm; Glucose; Glutamine; Humans; Jet Lag Syndrome; Lung; Lung Neoplasms; Mice, Inbred C57BL; Mutation; Period Circadian Proteins; Proto-Oncogene Proteins c-myc | 2016 |
Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells.
Topics: Animals; Autophagy; Autophagy-Related Protein 7; Cell Line, Tumor; Energy Metabolism; Gene Deletion; Genetic Variation; Genome, Mitochondrial; Glutamine; Lung Neoplasms; Mice; Mitochondria; Nucleosides; Nucleotides; Oxidation-Reduction; ras Proteins | 2016 |
Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glutamine; Humans; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?
Topics: A549 Cells; Amino Acid Transport System ASC; Antineoplastic Agents; Biological Transport, Active; Cisplatin; Glutamine; Humans; Lung Neoplasms; Minor Histocompatibility Antigens; Neoplasm Proteins; Prodrugs | 2017 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
Hypoxia promotes mitochondrial glutamine metabolism through HIF1α-GDH pathway in human lung cancer cells.
Topics: A549 Cells; Adenosine Triphosphate; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Glutamate Dehydrogenase; Glutamine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mitochondria; RNA, Messenger; RNA, Neoplasm; Signal Transduction | 2017 |
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Benzeneacetamides; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Glutaminase; Glutamine; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Radiopharmaceuticals; RNA Interference; Thiadiazoles; Transplantation, Heterologous | 2017 |
Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Amplification; Glucose; Glutamine; Glycolysis; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Malate Dehydrogenase; Neoplasms | 2017 |
Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters.
Topics: Acute Disease; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Esophagitis; Female; Follow-Up Studies; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Retrospective Studies; Treatment Outcome | 2009 |
Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Colorectal Neoplasms; Esophageal Neoplasms; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Head and Neck Neoplasms; Humans; Incidence; Isoleucine; Japan; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasms; Polymorphism, Single Nucleotide; Proline; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Risk Factors | 2010 |
Two Gln187 mutants of human soluble APRIL inhibit proliferation of lung carcinoma A549 cells.
Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Glutamine; Humans; Lung Neoplasms; Male; MAP Kinase Kinase Kinases; Mice; Sequence Alignment; Signal Transduction; Tumor Necrosis Factor Ligand Superfamily Member 13; Xenograft Model Antitumor Assays | 2009 |
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Topics: Aerobiosis; Animals; Cell Adhesion; Cell Proliferation; Cell Transformation, Neoplastic; Electron Transport Complex III; Extracellular Signal-Regulated MAP Kinases; Glutamine; Glycolysis; HCT116 Cells; Humans; Lung Neoplasms; Mice; Mitochondria; Oxidative Phosphorylation; Pentose Phosphate Pathway; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species | 2010 |
Inhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growth.
Topics: Adenosine Triphosphate; Adenylate Kinase; Alanine; Alanine Transaminase; Animals; Binding, Competitive; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Computational Biology; Energy Metabolism; Enzyme Activation; Enzyme Inhibitors; Glucose; Glutamine; Lung Neoplasms; Mice; Mitochondria; Oxidation-Reduction; Reactive Oxygen Species; Signal Transduction | 2011 |
Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer.
Topics: Chromatography, High Pressure Liquid; Creatinine; Erythritol; Gas Chromatography-Mass Spectrometry; Glutamine; Glycerylphosphorylcholine; Humans; Lung Neoplasms; Mass Spectrometry; Metabolomics; Palmitic Acid; Plasma; Serum; Small Cell Lung Carcinoma | 2011 |
Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis.
Topics: Animals; Cell Line, Tumor; Female; Glutamine; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Platelet Activating Factor | 2012 |
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Transformation, Neoplastic; Citric Acid Cycle; DNA Primers; Glucokinase; Glucose; Glutamine; Humans; Immunoblotting; Immunohistochemistry; Isotope Labeling; Lactic Acid; Liver Neoplasms, Experimental; Lung Neoplasms; Metabolome; Mice; Nuclear Magnetic Resonance, Biomolecular; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-myc; RNA Interference | 2012 |
Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Glutaminase; Glutamine; Glycolysis; Humans; Lung Neoplasms; Molecular Targeted Therapy; Protein Isoforms | 2012 |
Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Chemotherapy, Adjuvant; Disease-Free Survival; Esophagitis; Female; Follow-Up Studies; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome | 2012 |
SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Topics: Adult; Aged; Amino Acid Transport System ASC; Biological Transport; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Minor Histocompatibility Antigens; Reactive Oxygen Species; RNA Interference; Sex Factors; Signal Transduction; TOR Serine-Threonine Kinases | 2013 |
FREE AMINO ACIDS OF HUMAN BREAST CANCER.
Topics: Amino Acids; Asparagine; Aspartic Acid; Breast Neoplasms; Chromatography; Citrulline; Glutamates; Glutamine; Glycine; Humans; Isoleucine; Leucine; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Proline; Research; Serine; Threonine; Tyrosine | 1964 |
[Anti-proliferative effects of biochemical defense modifier antineoplaston in colorectal carcinoma].
Topics: Animals; Apoptosis; Benzeneacetamides; Cell Cycle; Cell Cycle Proteins; Colorectal Neoplasms; Depression, Chemical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Glutamine; Humans; Lung Neoplasms; Mice; Mice, Nude; Phenylacetates; Piperidones; Tumor Cells, Cultured | 2003 |
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
Topics: Adult; Aged; Alleles; Arginine; Aspartic Acid; Codon; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA-Binding Proteins; Environment; Female; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Glutamine; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk; Risk Factors; Smoking; X-ray Repair Cross Complementing Protein 1 | 2004 |
Effects of antineoplaston AS2-1 against post-operative lung metastasis in orthotopically implanted colon cancer in nude rat.
Topics: Animals; Carcinoma; Colonic Neoplasms; Drug Combinations; G1 Phase; Glutamine; In Situ Nick-End Labeling; Lung Neoplasms; Male; Neoplasms, Experimental; Phenylacetates; Rats; Rats, Inbred F344 | 2005 |
Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers.
Topics: Adult; Aged; Amino Acid Substitution; Arginine; Asbestos; Comet Assay; DNA Damage; DNA Repair; DNA-Binding Proteins; Genotype; Glutamine; Humans; Hydrogen Peroxide; Lung Neoplasms; Lymphocytes; Middle Aged; Occupational Exposure; Polymerase Chain Reaction; Polymorphism, Genetic; X-ray Repair Cross Complementing Protein 1 | 2006 |
Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells.
Topics: Amino Acids, Essential; Apoptosis; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Culture Media, Serum-Free; Eukaryotic Initiation Factor-2; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Humans; Lung Neoplasms; Necrosis; Protein Serine-Threonine Kinases; RNA, Messenger; Signal Transduction; Stress, Physiological; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2007 |
Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population.
Topics: Amino Acid Substitution; Arginine; Case-Control Studies; Codon; DNA Repair; DNA-Binding Proteins; Female; Genotype; Glutamine; Humans; India; Lung Neoplasms; Male; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Population; Risk; Tryptophan; X-ray Repair Cross Complementing Protein 1 | 2007 |
Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study.
Topics: Acute Disease; Administration, Oral; Aged; Combined Modality Therapy; Esophagitis; Esophagus; Feasibility Studies; Female; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage | 2007 |
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.
Topics: Base Sequence; Cell Line; Cell Transformation, Neoplastic; Cloning, Molecular; Glutamine; Humans; Leucine; Lung Neoplasms; Mutation; Oncogenes; Proto-Oncogene Mas; Urinary Bladder Neoplasms | 1983 |
Effect of glutamine on tumor and host growth.
Topics: Adenocarcinoma; Aneuploidy; Animals; Body Weight; Cell Cycle; DNA; Female; Glutamine; Glycerol; Growth; Ileum; Intestinal Mucosa; Lung Neoplasms; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; RNA; Soft Tissue Neoplasms | 1995 |
p53 alterations in plutonium-induced F344 rat lung tumors.
Topics: Adenocarcinoma; Aerosols; Amino Acid Sequence; Animals; Blotting, Southern; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; DNA Primers; DNA, Neoplasm; Exons; Female; Genes, p53; Glutamine; Immunohistochemistry; Lung Neoplasms; Lysine; Molecular Sequence Data; Mutagenesis; Neoplasms, Radiation-Induced; Plutonium; Point Mutation; Polymerase Chain Reaction; Rats; Rats, Inbred F344; Tumor Suppressor Protein p53 | 1995 |
1H-magnetic resonance spectroscopic observation of cultured malignant cells pharmacologically induced to different phenotypes.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Butyrates; Butyric Acid; Choline; Creatine; Dexamethasone; Glutamic Acid; Glutamine; Histone Deacetylase Inhibitors; Humans; Hydrogen; Interferon-gamma; Lactates; Lung Neoplasms; Magnetic Resonance Spectroscopy; Phenotype; Phospholipids; Phosphorylcholine; Triglycerides; Tumor Cells, Cultured | 1996 |
The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alleles; DNA-Binding Proteins; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Glutamine; Humans; Lung Neoplasms; Middle Aged; Risk Factors; X-ray Repair Cross Complementing Protein 1 | 2001 |
Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Azo Compounds; Biological Transport; Colonic Neoplasms; Diazooxonorleucine; Drug Resistance; Glutamine; Humans; Isoxazoles; Kinetics; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxazoles; Tumor Cells, Cultured | 1988 |
Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
Topics: Antimetabolites; Azo Compounds; Cell Cycle; Cell Line; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Glutaminase; Glutamine; Humans; Isoxazoles; Lung Neoplasms; Neoplasms, Experimental; Oxazoles | 1987 |
Influence of reduced concentration of L-glutamine on growth and viability of cells in monolayer, in spheroids, and in experimental tumours.
Topics: Animals; Cell Survival; Cells, Cultured; Fibrosarcoma; Glutaminase; Glutamine; Humans; Lung Neoplasms; Mice; Neoplasms, Experimental; Time Factors; Urinary Bladder Neoplasms | 1986 |
Isolation of tumor-secreted products from human carcinoma cells maintained in a defined protein-free medium.
Topics: Carcinoembryonic Antigen; Carcinoma; Cell Line; Colonic Neoplasms; Culture Media; Fibrosarcoma; Glutamine; Growth Substances; Humans; Lung Neoplasms; Muramidase; Proteins | 1985 |
[Controlled clinical trial of a preparation with steroid activity (prednisone) associated with xylamide, protective drug for the gastric mucosa].
Topics: Adolescent; Adult; Aged; Amides; Arthritis, Rheumatoid; Asthma; Benzoates; Bronchitis; Chronic Disease; Drug Combinations; Endocarditis; Erythema; Evaluation Studies as Topic; Gastric Mucosa; Glutamine; Hepatitis A; Hodgkin Disease; Humans; Joint Diseases; Lung Neoplasms; Middle Aged; Prednisone; Urticaria | 1972 |